Latest Legal News
Kishish Law Group provides semi-regular legal news focused on the areas of mass tort lawsuits, class actions, and product liability.
SGLT2 Inhibitors, like Invokana, Found to Double Risk of Diabetic Ketoacidosis
June 8, 2017 - pharmaceutical
Doctors find certain diabetes drugs can increase the chance for potentially fatal acidic blood condition. In a June 8, 2017 correspondence to the New England Journal of Medicine, doctors associated with Harvard Medical School wrote that SGLT2 inhibitors, a class of type 2 diabetes drugs that includes Invokana and Invokamet, can double the risk of diabetic ketoacidosis when compared to DPP4 inhibitors, a different kind of diabetes drug. The researchers identified patients who had recently started treatment of their diabetes...
Continue ReadingDiabetes Drug Invokana Linked to Amputation Risk
May 23, 2017 - pharmaceutical
Trials find the drug doubles the risk of leg and foot amputation In a recent communication, the U.S. Food and Drug Administration (FDA) warned patients that taking the type 2 diabetes drug canagliflozin (Invokana, Invokamet, Invokamet XR) can cause an increased risk of leg and foot amputations. The FDA says patients taking Invokana and similar drugs should notify their doctor as soon as possible if they find new pain and tenderness in their feet and legs. Invokana and Invokamet are...
Continue ReadingOver 30% of Drugs Had Safety Problems After FDA Approval
May 17, 2017 - pharmaceutical
Scientists at Yale find approval not a guarantor of drug safety Researchers at the Yale School of Medicine have published a 2017 report showing that of 222 drugs the U.S. Food and Drug Administration (FDA) approved between 2001 and 2010, 71 were affected by safety events after they had already been sold to patients. Dr. Joseph Ross and his colleagues studied the FDA’s approval process for new drugs and found that the median time from the FDA’s approval of the...
Continue ReadingXarelto® Bellwether Cases Begin
April 28, 2017 - pharmaceutical
Over 18,000 patients accuse Johnson & Johnson and Bayer of failing to inform doctors about the dangers of the blood-thinning drug. On April 24th, a bellwether trial began in the lawsuit against the stroke drug, Xarelto, manufactured by Johnson & Johnson and Bayer. The plaintiffs accuse the pharmaceutical companies of failing to provide sufficient information about the risks involved in taking Xarelto, including what the plaintiffs claim is a high chance for severe bleeding events. The Chicago Tribune reports that...
Continue ReadingMinor Mistake May Have Caused Denial of TSGLI Claim
April 3, 2017 - veteran
The Military Times recently reported on the case of Sgt. 1st Class Cameron Corder, a soldier who broke his back in a helicopter accident in Afghanistan in 2013. Corder, a Michigan native and army medic, was treating a Marine injured in an IED blast when his injury happened. The Marine that Corder was treating, likely suffering shock, became aggressive inside the helicopter and tackled Corder to the floor. Corder says that he fell into medical equipment inside the helicopter and...
Continue ReadingSearch
Speak with a Lawyer
Contact an attorney today for a free and confidential legal consultation.